[Renal failure after allogeneic hematopoietic stem cell transplantation: Recommendations of the Francophone Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].

Insuffisance rénale et allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).

Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 20 01 2019
revised: 05 05 2019
accepted: 09 05 2019
pubmed: 16 7 2019
medline: 4 3 2020
entrez: 16 7 2019
Statut: ppublish

Résumé

Acute and chronic renal failures are very common after allogeneic HSCT. These complications have a real impact on mortality and morbidity of transplant recipients. Within the framework of the ninth workshops of practice harmonization of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) held in Lille in September 2018, various causes and mechanisms of renal failure, diagnostic work-up, treatment and recommendations to limit renal failure after transplantation are reviewed. Recommendations to adjust medications to avoid renal failure are also proposed in this article.

Identifiants

pubmed: 31303250
pii: S0007-4551(19)30226-7
doi: 10.1016/j.bulcan.2019.05.002
pii:
doi:

Substances chimiques

Anti-Infective Agents 0
Immunosuppressive Agents 0

Types de publication

Consensus Development Conference Journal Article Practice Guideline

Langues

fre

Sous-ensembles de citation

IM

Pagination

S28-S35

Informations de copyright

Copyright © 2019 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Marie Detrait (M)

CHU de Nancy, hôpitaux de Brabois, service d'hématologie, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France. Electronic address: m.detrait@chru-nancy.fr.

Eva de Berranger (E)

CHRU de Lille, hôpital Jeanne-de-Flandres, service d'hématologie pédiatrique, avenue Eugène-Aviné, 59037 Lille cedex, France.

Remy Dulery (R)

Hôpital Saint-Antoine, service d'hématologie clinique, 184, rue de Faubourg Saint-Antoine, 75012 Paris, France.

Anne-Lise Ménard (AL)

Centre Henri-Becquerel, département d'hématologie clinique, rue d'Amiens, 76038 Rouen, France.

Sylvain Thépot (S)

CHU d'Angers, service d'hématologie, 4, rue Larrey, 49033 Angers, France.

Selami Kocak Toprak (SK)

Hôpital Cebeci, université d'Ankara, faculté de médecine, service d'hématologie, Tip Fakultesi Caddesi, Dikimevi, 06620 Ankara, Turquie.

Pascal Turlure (P)

CHU de Limoges, service d'hématologie, 2, avenue Martin-Luther-King, 87000 Limoges, France.

Ibrahim Yakoub-Agha (I)

CHU de Lille, LIRIC, Inserm U995, université de Lille, service d'hématologie, 59000 Lille, France.

Thierry Guillaume (T)

CHU de Nantes, Hôtel-Dieu, service d'hématologie clinique, 1, place Ricordeau, 44000 Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH